Taylor, S., Gruen, M., KuKanich, K., Lascelles, B.D.X., Monteiro, B.P., Sampietro, L.R., Robertson, S. and Steagall, P.V. | Journal of Feline Medicine and Surgery | April 2024
The aim of these consensus guidelines is to provide veterinary practitioners with information on the appropriate use of non-steroidal anti-inflammatory drugs in the management of chronic pain in cats…
| Veterinary Record | 2021 | The objective of this prospective randomised controlled trial was to confirm the safety and efficacy of enflicoxib for the treatment of naturally occurring osteoarthritis (OA) in dogs …
K. Kasiora, A. Anagnostopoulos, C. Bedford, T. Menka, M. Barden, B.E. Griffiths, D. Achard, K. Timms, V. Silva Machado, A. Coates and G. Oikonomou | Veterinary Record | October 2021
The objective of this randomised, positively controlled study was to evaluate the potential benefits of ketoprofen in cows with active digital dermatitis (DD)…
M. Salichs, L. Badiella, P. Sarasola and J. Homedes | Veterinary Record | September 2021
The aim of this prospective randomised controlled trial was to confirm the safety and efficacy of enflicoxib for the treatment of naturally occurring osteoarthritis (OA) in dogs…
| Journal of the American Veterinary Medical Association | 2021 | The aim of this randomised placebo-controlled, double-blinded trial was to assess the impact of prophylactic administration of omeprazole or famotidine on the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam …
M.H. Shaevitz, G.E. Moore and C.M. Fulkerson | Journal of the American Veterinary Medical Association | August 2021
The aim of this randomised placebo-controlled, double-blinded trial, which was carried at a Veterinary Teaching Hospital in the United States and funded by the Veterinary Cancer Society’s Resident Research Award, was to assess the impact of prophylactic administration of omeprazole or famotidine on the incidence and severity of gastrointestinal (GI) adverse events (AEs) in dogs with cancer treated with piroxicam…
Connect with us